0001829126-26-009173 Sample Contracts
COMMON STOCK PURCHASE WARRANT NEXALIN TECHNOLOGY, INC.Security Agreement • August 20th, 2026 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alumni Capital LP or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Initial Exercise Date”)and on or prior to 5:00 p.m. (New York City time) on the one-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nexalin Technology, Inc., a Delaware corporation (the “Company”), up to 1,209,677 shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 20th, 2026 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of August 19, 2026, between Nexalin Technology, Inc., a Delaware corporation (the “Company”), and Alumni Capital LP, a Delaware limited partnership (including its successors and assigns, a “Purchaser”).
PRE-FUNDED COMMON SHARE PURCHASE WARRANT NEXALIN TECHNOLOGY, INC.Pre-Funded Warrant Agreement • August 20th, 2026 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alumni Capital LP, a Delaware limited partnership or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nexalin Technology, Inc., a Delaware corporation (the “Company”), Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THESE REDACTED TERMS HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS AS [***]. ANY...Any Market Purchase Agreement • August 20th, 2026 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Any Market Purchase Agreement (this “Agreement”), dated as of August 19, 2026 (the “Execution Date”), by and between Nexalin Technology, Inc., a Delaware corporation (the “Company”), and Alumni Capital LP, a Delaware limited partnership (the “Investor”, together with the Company, the “Parties”, and each a “Party”).